Inge Van der Sluis

17PUBLICATIONS
77CO-AUTHORS
Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyCancer geneticsNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 11, 2026
Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

|Jul 24, 2026
Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALL.

|Feb 27, 2026
Drivers of Methotrexate Polyglutamate Concentration in Erythrocytes: Insights from Immune-Mediated Inflammatory Diseases and Pediatric Acute Lymphoblastic Leukemia.

Janani Sundaresan, Wout J Hamelink, Renske C F Hebing

|Jan 08, 2026
Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.

Miguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha

|Feb 28, 2025
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL.

Judith M Boer, Marco J Koudijs, Lennart A Kester

|Jun 26, 2024
Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group Study.

Stavroula Anastasopoulou, Gemma Swann, Liv Andres-Jensen

Pageof 3

Frequent Collaborators

5 joint publications

Rob Pieters

4 joint publications

Franco Locatelli

3 joint publications

Valerie de Haas

3 joint publications

Monique L den Boer